The effects of a multigrowth factor-containing cream on recovery after laser treatment: a double-blinded, randomized, split-face controlled study

2016 ◽  
Vol 16 (1) ◽  
pp. 76-83 ◽  
Author(s):  
Sungsik Shin ◽  
Jung U Shin ◽  
Youngin Lee ◽  
Tae Gwang Kwon ◽  
Ju Hee Lee
Keyword(s):  
Laser Treatment ◽  
Controlled Study ◽  
Double Blinded ◽  
Split Face

Administration of skin care regimens containing β‐glucan for skin recovery after fractional laser therapy: A split‐face, double‐blinded, vehicle‐controlled study

2020 ◽  
Author(s):  
Yajing Cao ◽  
Peiru Wang ◽  
Guolong Zhang ◽  
Chan Hu ◽  
Haiyan Zhang ◽  
...  
Keyword(s):  
Laser Therapy ◽  
Skin Care ◽  
Controlled Study ◽  
Fractional Laser ◽  
Double Blinded ◽  
Split Face

The efficacy and safety of multilamellar vesicle containing retinaldehyde: A double‐blinded, randomized, split‐face controlled study

2021 ◽  
Author(s):  
Jemin Kim ◽  
Jihee Kim ◽  
Tunyaporn Jongudomsombat ◽  
Eunbin Kim BS ◽  
Jangmi Suk ◽  
...  
Keyword(s):  
Controlled Study ◽  
Efficacy And Safety ◽  
Multilamellar Vesicle ◽  
Double Blinded ◽  
Split Face

Desflurane is not inferior to sevoflurane in the occurrence of adverse respiratory events during laryngeal mask airway anesthesia: a non-inferiority randomized double-blinded controlled study

2020 ◽  
Vol 86 (6) ◽  
Author(s):  
Pathomporn Pin-On ◽  
Prangmalee Leurcharusmee ◽  
Suwannee Tanasungnuchit ◽  
Katekanog Srivita ◽  
Parichad Khunwittaya
Keyword(s):  
Laryngeal Mask Airway ◽  
Laryngeal Mask ◽  
Controlled Study ◽  
Respiratory Events ◽  
Double Blinded ◽  
Adverse Respiratory Events

Effects of dexmedetomidine on inflammatory mediators after tourniquet-induced ischemia-reperfusion injury: a randomized, double-blinded, controlled study

2019 ◽  
Vol 85 (3) ◽  
Author(s):  
Seung H. Kim ◽  
Do-Hyeong Kim ◽  
Seokyung Shin ◽  
Seon J. Kim ◽  
Tae L. Kim ◽  
...  
Keyword(s):  
Reperfusion Injury ◽  
Inflammatory Mediators ◽  
Ischemia Reperfusion Injury ◽  
Ischemia Reperfusion ◽  
Controlled Study ◽  
Double Blinded

Oral Alpha Lipoic Acid Treatment for Symptomatic Diabetic Peripheral Neuropathy: A Randomized Double-Blinded Placebo-Controlled Study

2020 ◽  
Vol 20 (9) ◽  
pp. 1531-1534 ◽  
Author(s):  
Mamdouh R. El-Nahas ◽  
Ghada Elkannishy ◽  
Hala Abdelhafez ◽  
Enas T. Elkhamisy ◽  
Amr A. El-Sehrawy
Keyword(s):  
Peripheral Neuropathy ◽  
Lipoic Acid ◽  
Diabetic Peripheral Neuropathy ◽  
Study Groups ◽  
Controlled Study ◽  
Alpha Lipoic Acid ◽  
Disability Score ◽  
Perception Threshold ◽  
Outcome Parameters ◽  
Double Blinded

Background: Alpha-lipoic acid (ALA) was used in the treatment of diabetic peripheral neuropathy (DPN) using different routes, doses and treatment durations. The aim of this work is to assess the efficacy of oral 600mg ALA twice daily over 6 months in the treatment of patients with DPN. Methods: This is a prospective, single-center, double-blinded, placebo-controlled study conducted at the outpatient clinic of Mansoura Specialized Hospital, Mansoura University. A total of 200 patients with DPN were randomly assigned to add on treatment with either oral 600mg twice daily ALA (n=100) or placebo (n=100) for 6 months. Treatment outcome was assessed using vibration perception threshold (VPT), neurological symptom score (NSS), neurological disability score (NDS), and visual analog scale (VAS) for pain at baseline and at each visit (1, 3 and 6 months) after the start of treatment. Results: Comparison between the study groups regarding the baseline data revealed no statistically significant differences. with respect to the outcome parameters, no significant differences were found between the studied groups at baseline. However, in subsequent visits, ALA-treated patients had significantly better results regarding almost all the outcome parameters (NSS, NDS, VAS, VPT). Mild nausea was reported in 6 patients. None of the studied patients discontinued treatment. Conclusions: Oral 600mg ALA twice-daily treatment for DPN over 6 months is effective, safe and tolerable.

Botulinum toxin improves forehead scars after Mohs surgery: a randomized, double-blinded, controlled study

2021 ◽  
Author(s):  
Matthew J. Lin ◽  
Daniel M. Bernstein ◽  
Richard L. Torbeck ◽  
Danielle P. Dubin ◽  
Joshua D. Rosenberg ◽  
...  
Keyword(s):  
Botulinum Toxin ◽  
Controlled Study ◽  
Mohs Surgery ◽  
Double Blinded
Sign in / Sign up

Export Citation Format

Share Document